ht 1080 tumor cell line Search Results


98
ATCC human ht 1080 tumor cell line 29
Human Ht 1080 Tumor Cell Line 29, supplied by ATCC, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human ht 1080 tumor cell line 29/product/ATCC
Average 98 stars, based on 1 article reviews
human ht 1080 tumor cell line 29 - by Bioz Stars, 2026-04
98/100 stars
  Buy from Supplier

95
ATCC human fibrosarcoma tumor cell line
Human Fibrosarcoma Tumor Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human fibrosarcoma tumor cell line/product/ATCC
Average 95 stars, based on 1 article reviews
human fibrosarcoma tumor cell line - by Bioz Stars, 2026-04
95/100 stars
  Buy from Supplier

93
DSMZ mesenchymal cell line tumour
Mesenchymal Cell Line Tumour, supplied by DSMZ, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mesenchymal cell line tumour/product/DSMZ
Average 93 stars, based on 1 article reviews
mesenchymal cell line tumour - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier

99
Thermo Fisher adherent tumor cells
Adherent Tumor Cells, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/adherent tumor cells/product/Thermo Fisher
Average 99 stars, based on 1 article reviews
adherent tumor cells - by Bioz Stars, 2026-04
99/100 stars
  Buy from Supplier

90
Harlan Laboratories five million ht-1080 cells
Confocal microscopy results of Cy5.5-NGR2 with <t>HT-1080</t> cells (CD13 positive) and MCF-7 cells (CD13 negative) (magnification: 100×). The blocking study is achieved by adding unlabeled monomeric NGR peptide. Top: Incubation of Cy5.5-NGR2 (20 nM) with CD13-positive HT-1080 cells; middle: incubation of Cy5.5-NGR2 (20 nM) with CD13-positive HT-1080 cells blocked by a non-labeled monomeric NGR peptide (50 μM); bottom: incubation of Cy5.5-NGR2 (20 nM) with CD13-negative MCF-7 cells. Reproduced from Ref. 6 with permission from Springer
Five Million Ht 1080 Cells, supplied by Harlan Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/five million ht-1080 cells/product/Harlan Laboratories
Average 90 stars, based on 1 article reviews
five million ht-1080 cells - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

99
ATCC tumor cells lines
Confocal microscopy results of Cy5.5-NGR2 with <t>HT-1080</t> cells (CD13 positive) and MCF-7 cells (CD13 negative) (magnification: 100×). The blocking study is achieved by adding unlabeled monomeric NGR peptide. Top: Incubation of Cy5.5-NGR2 (20 nM) with CD13-positive HT-1080 cells; middle: incubation of Cy5.5-NGR2 (20 nM) with CD13-positive HT-1080 cells blocked by a non-labeled monomeric NGR peptide (50 μM); bottom: incubation of Cy5.5-NGR2 (20 nM) with CD13-negative MCF-7 cells. Reproduced from Ref. 6 with permission from Springer
Tumor Cells Lines, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/tumor cells lines/product/ATCC
Average 99 stars, based on 1 article reviews
tumor cells lines - by Bioz Stars, 2026-04
99/100 stars
  Buy from Supplier

93
ATCC tumor cell lines ht1080 luc cells
Confocal microscopy results of Cy5.5-NGR2 with <t>HT-1080</t> cells (CD13 positive) and MCF-7 cells (CD13 negative) (magnification: 100×). The blocking study is achieved by adding unlabeled monomeric NGR peptide. Top: Incubation of Cy5.5-NGR2 (20 nM) with CD13-positive HT-1080 cells; middle: incubation of Cy5.5-NGR2 (20 nM) with CD13-positive HT-1080 cells blocked by a non-labeled monomeric NGR peptide (50 μM); bottom: incubation of Cy5.5-NGR2 (20 nM) with CD13-negative MCF-7 cells. Reproduced from Ref. 6 with permission from Springer
Tumor Cell Lines Ht1080 Luc Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/tumor cell lines ht1080 luc cells/product/ATCC
Average 93 stars, based on 1 article reviews
tumor cell lines ht1080 luc cells - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier

90
WuXi AppTec ht-1080 cells
Confocal microscopy results of Cy5.5-NGR2 with <t>HT-1080</t> cells (CD13 positive) and MCF-7 cells (CD13 negative) (magnification: 100×). The blocking study is achieved by adding unlabeled monomeric NGR peptide. Top: Incubation of Cy5.5-NGR2 (20 nM) with CD13-positive HT-1080 cells; middle: incubation of Cy5.5-NGR2 (20 nM) with CD13-positive HT-1080 cells blocked by a non-labeled monomeric NGR peptide (50 μM); bottom: incubation of Cy5.5-NGR2 (20 nM) with CD13-negative MCF-7 cells. Reproduced from Ref. 6 with permission from Springer
Ht 1080 Cells, supplied by WuXi AppTec, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ht-1080 cells/product/WuXi AppTec
Average 90 stars, based on 1 article reviews
ht-1080 cells - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
National Centre for Cell Science human fibrosarcoma tumor cells ht-1080
Confocal microscopy results of Cy5.5-NGR2 with <t>HT-1080</t> cells (CD13 positive) and MCF-7 cells (CD13 negative) (magnification: 100×). The blocking study is achieved by adding unlabeled monomeric NGR peptide. Top: Incubation of Cy5.5-NGR2 (20 nM) with CD13-positive HT-1080 cells; middle: incubation of Cy5.5-NGR2 (20 nM) with CD13-positive HT-1080 cells blocked by a non-labeled monomeric NGR peptide (50 μM); bottom: incubation of Cy5.5-NGR2 (20 nM) with CD13-negative MCF-7 cells. Reproduced from Ref. 6 with permission from Springer
Human Fibrosarcoma Tumor Cells Ht 1080, supplied by National Centre for Cell Science, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human fibrosarcoma tumor cells ht-1080/product/National Centre for Cell Science
Average 90 stars, based on 1 article reviews
human fibrosarcoma tumor cells ht-1080 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

97
JASCO Inc v-730
Confocal microscopy results of Cy5.5-NGR2 with <t>HT-1080</t> cells (CD13 positive) and MCF-7 cells (CD13 negative) (magnification: 100×). The blocking study is achieved by adding unlabeled monomeric NGR peptide. Top: Incubation of Cy5.5-NGR2 (20 nM) with CD13-positive HT-1080 cells; middle: incubation of Cy5.5-NGR2 (20 nM) with CD13-positive HT-1080 cells blocked by a non-labeled monomeric NGR peptide (50 μM); bottom: incubation of Cy5.5-NGR2 (20 nM) with CD13-negative MCF-7 cells. Reproduced from Ref. 6 with permission from Springer
V 730, supplied by JASCO Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/v-730/product/JASCO Inc
Average 97 stars, based on 1 article reviews
v-730 - by Bioz Stars, 2026-04
97/100 stars
  Buy from Supplier

97
Cytoskeleton Inc tubulin polymerization assay using >99% pure tubulin, fluorescence based
Confocal microscopy results of Cy5.5-NGR2 with <t>HT-1080</t> cells (CD13 positive) and MCF-7 cells (CD13 negative) (magnification: 100×). The blocking study is achieved by adding unlabeled monomeric NGR peptide. Top: Incubation of Cy5.5-NGR2 (20 nM) with CD13-positive HT-1080 cells; middle: incubation of Cy5.5-NGR2 (20 nM) with CD13-positive HT-1080 cells blocked by a non-labeled monomeric NGR peptide (50 μM); bottom: incubation of Cy5.5-NGR2 (20 nM) with CD13-negative MCF-7 cells. Reproduced from Ref. 6 with permission from Springer
Tubulin Polymerization Assay Using >99% Pure Tubulin, Fluorescence Based, supplied by Cytoskeleton Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/tubulin polymerization assay using >99% pure tubulin, fluorescence based/product/Cytoskeleton Inc
Average 97 stars, based on 1 article reviews
tubulin polymerization assay using >99% pure tubulin, fluorescence based - by Bioz Stars, 2026-04
97/100 stars
  Buy from Supplier

99
JASCO Inc jasco uv-visible nir spectrophotometer
Confocal microscopy results of Cy5.5-NGR2 with <t>HT-1080</t> cells (CD13 positive) and MCF-7 cells (CD13 negative) (magnification: 100×). The blocking study is achieved by adding unlabeled monomeric NGR peptide. Top: Incubation of Cy5.5-NGR2 (20 nM) with CD13-positive HT-1080 cells; middle: incubation of Cy5.5-NGR2 (20 nM) with CD13-positive HT-1080 cells blocked by a non-labeled monomeric NGR peptide (50 μM); bottom: incubation of Cy5.5-NGR2 (20 nM) with CD13-negative MCF-7 cells. Reproduced from Ref. 6 with permission from Springer
Jasco Uv Visible Nir Spectrophotometer, supplied by JASCO Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/jasco uv-visible nir spectrophotometer/product/JASCO Inc
Average 99 stars, based on 1 article reviews
jasco uv-visible nir spectrophotometer - by Bioz Stars, 2026-04
99/100 stars
  Buy from Supplier

Image Search Results


Confocal microscopy results of Cy5.5-NGR2 with HT-1080 cells (CD13 positive) and MCF-7 cells (CD13 negative) (magnification: 100×). The blocking study is achieved by adding unlabeled monomeric NGR peptide. Top: Incubation of Cy5.5-NGR2 (20 nM) with CD13-positive HT-1080 cells; middle: incubation of Cy5.5-NGR2 (20 nM) with CD13-positive HT-1080 cells blocked by a non-labeled monomeric NGR peptide (50 μM); bottom: incubation of Cy5.5-NGR2 (20 nM) with CD13-negative MCF-7 cells. Reproduced from Ref. 6 with permission from Springer

Journal: Methods in molecular biology (Clifton, N.J.)

Article Title: In Vivo Tumor Angiogenesis Imaging Using Peptide-Based Near-Infrared Fluorescent Probes

doi: 10.1007/978-1-4939-3721-9_8

Figure Lengend Snippet: Confocal microscopy results of Cy5.5-NGR2 with HT-1080 cells (CD13 positive) and MCF-7 cells (CD13 negative) (magnification: 100×). The blocking study is achieved by adding unlabeled monomeric NGR peptide. Top: Incubation of Cy5.5-NGR2 (20 nM) with CD13-positive HT-1080 cells; middle: incubation of Cy5.5-NGR2 (20 nM) with CD13-positive HT-1080 cells blocked by a non-labeled monomeric NGR peptide (50 μM); bottom: incubation of Cy5.5-NGR2 (20 nM) with CD13-negative MCF-7 cells. Reproduced from Ref. 6 with permission from Springer

Article Snippet: list-behavior=enumerated prefix-word= mark-type=decimal max-label-size=0 Generate the tumor xenografts by subcutaneous injection of five million HT-1080 cells suspended in 50 μL of cell culture media and 50 μL of BD Matrigel into the right shoulder of female athymic nude mice (Harlan Laboratories, Livermore, CA, USA) ( see Note 9 ).

Techniques: Confocal Microscopy, Blocking Assay, Incubation, Labeling

Time-course fluorescence imaging of subcutaneous HT-1080 tumor-bearing nude mice after intravenous injection of 1.5 nmol of Cy5.5-NGR2. The tumors are clearly visualized as indicated by an arrow from 0.5 to 4 h pi. The fluorescence intensity is recorded as per second per centimeter squared per steradian (p/s/cm2/sr). Reproduced from Ref. 6 with permission from Springer

Journal: Methods in molecular biology (Clifton, N.J.)

Article Title: In Vivo Tumor Angiogenesis Imaging Using Peptide-Based Near-Infrared Fluorescent Probes

doi: 10.1007/978-1-4939-3721-9_8

Figure Lengend Snippet: Time-course fluorescence imaging of subcutaneous HT-1080 tumor-bearing nude mice after intravenous injection of 1.5 nmol of Cy5.5-NGR2. The tumors are clearly visualized as indicated by an arrow from 0.5 to 4 h pi. The fluorescence intensity is recorded as per second per centimeter squared per steradian (p/s/cm2/sr). Reproduced from Ref. 6 with permission from Springer

Article Snippet: list-behavior=enumerated prefix-word= mark-type=decimal max-label-size=0 Generate the tumor xenografts by subcutaneous injection of five million HT-1080 cells suspended in 50 μL of cell culture media and 50 μL of BD Matrigel into the right shoulder of female athymic nude mice (Harlan Laboratories, Livermore, CA, USA) ( see Note 9 ).

Techniques: Fluorescence, Imaging, Injection

Quantification and kinetics of in vivo targeting character of Cy5.5-NGR2 in the HT-1080 tumor vs. muscle. The Cy5.5-NGR2 uptake in HT-1080 tumor at various time points is significantly higher than that in muscle. Error bar is calculated as the standard deviation (n = 3). Reproduced from Ref. 6 with permission from Springer

Journal: Methods in molecular biology (Clifton, N.J.)

Article Title: In Vivo Tumor Angiogenesis Imaging Using Peptide-Based Near-Infrared Fluorescent Probes

doi: 10.1007/978-1-4939-3721-9_8

Figure Lengend Snippet: Quantification and kinetics of in vivo targeting character of Cy5.5-NGR2 in the HT-1080 tumor vs. muscle. The Cy5.5-NGR2 uptake in HT-1080 tumor at various time points is significantly higher than that in muscle. Error bar is calculated as the standard deviation (n = 3). Reproduced from Ref. 6 with permission from Springer

Article Snippet: list-behavior=enumerated prefix-word= mark-type=decimal max-label-size=0 Generate the tumor xenografts by subcutaneous injection of five million HT-1080 cells suspended in 50 μL of cell culture media and 50 μL of BD Matrigel into the right shoulder of female athymic nude mice (Harlan Laboratories, Livermore, CA, USA) ( see Note 9 ).

Techniques: In Vivo, Standard Deviation

Representative optical imaging (at 2 h pi) of mice bearing HT-1080 tumor on the right shoulder demonstrating blocking of Cy5.5-NGR2 (1.5 nmol) uptake by co-injection with a non-labeled monomeric NGR peptide (20 mg/kg). Reproduced from Ref. 6 with permission from Springer

Journal: Methods in molecular biology (Clifton, N.J.)

Article Title: In Vivo Tumor Angiogenesis Imaging Using Peptide-Based Near-Infrared Fluorescent Probes

doi: 10.1007/978-1-4939-3721-9_8

Figure Lengend Snippet: Representative optical imaging (at 2 h pi) of mice bearing HT-1080 tumor on the right shoulder demonstrating blocking of Cy5.5-NGR2 (1.5 nmol) uptake by co-injection with a non-labeled monomeric NGR peptide (20 mg/kg). Reproduced from Ref. 6 with permission from Springer

Article Snippet: list-behavior=enumerated prefix-word= mark-type=decimal max-label-size=0 Generate the tumor xenografts by subcutaneous injection of five million HT-1080 cells suspended in 50 μL of cell culture media and 50 μL of BD Matrigel into the right shoulder of female athymic nude mice (Harlan Laboratories, Livermore, CA, USA) ( see Note 9 ).

Techniques: Optical Imaging, Blocking Assay, Injection, Labeling

Fluorescence intensity ratio of tumor to muscle based on the ROI analysis of Cy5.5-NGR2 uptake at 2 h pi in HT-1080 tumors without (non-blocking) or with (blocking) co-injection of a non-labeled monomeric NGR peptide (20 mg/kg). Error bar is calculated as the standard deviation (n = 3). Reproduced from Ref. 6 with permission from Springer

Journal: Methods in molecular biology (Clifton, N.J.)

Article Title: In Vivo Tumor Angiogenesis Imaging Using Peptide-Based Near-Infrared Fluorescent Probes

doi: 10.1007/978-1-4939-3721-9_8

Figure Lengend Snippet: Fluorescence intensity ratio of tumor to muscle based on the ROI analysis of Cy5.5-NGR2 uptake at 2 h pi in HT-1080 tumors without (non-blocking) or with (blocking) co-injection of a non-labeled monomeric NGR peptide (20 mg/kg). Error bar is calculated as the standard deviation (n = 3). Reproduced from Ref. 6 with permission from Springer

Article Snippet: list-behavior=enumerated prefix-word= mark-type=decimal max-label-size=0 Generate the tumor xenografts by subcutaneous injection of five million HT-1080 cells suspended in 50 μL of cell culture media and 50 μL of BD Matrigel into the right shoulder of female athymic nude mice (Harlan Laboratories, Livermore, CA, USA) ( see Note 9 ).

Techniques: Fluorescence, Blocking Assay, Injection, Labeling, Standard Deviation